Our research demonstrated that the overall survival time was decreased in CRC patients with higher GPR116 expression regardless of TNM stage (Figure 3E-3F) and lymphatic metastasis by using Kaplan–Meier analysis (Figure 3G-3H). The gene discussed is ADGRF5; the disease is colorectal carcinoma.